Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating intravenous golimumab in pediatric patients with active polyarticular juvenile idiopathic arthritis despite methotrexate, reporting pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Polyarticular Juvenile Idiopathic Arthritis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Juvenile | Phase 3 | Status: COMPLETED | Results posted: 2020-11-18